İmalat

Total Market Cap 220,561.9B
P/E (Weighted)Price to Earnings ratio. 50.49 Medyan: 11.75
P/B (Weighted)Price to Book ratio. 5.00 Medyan: 1.77
P/E (Arithmetic)Simple average P/E. 26.92
Avg Lothien ScoreFinancial health score (0-100). 64
Avg DamodaranDamodaran scoring model. 50
Avg PotentialExpected upside potential %. +33.6%
Avg Dalio ScoreDalio debt cycle score. 71
Distributions
Lothien Distribution
0–25
0
25–40
7
40–55
5
55–70
11
70–100
16
Damodaran Distribution
0–25
5
25–40
7
40–55
10
55–70
11
70–100
6
Upside Potential
-100% – -20%
9
-20% – +0%
3
+0% – +20%
6
+20% – +50%
5
+50%+
16

Data date 2026-10-19 Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Data date 2026-10-19
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Stocks in Sector
Stock PriceCurrent trading price. Market CapTotal market capitalization. FKPrice to Earnings ratio. PD/DDPrice to Book ratio. EV/EBITDAEnterprise Value / EBITDA. ROICReturn on Invested Capital. WACCWeighted Average Cost of Capital (WACC). PUSLAFinancial health score (0-100). DamodaranValuation score. Intrinsic ValueFair value via DCF model. Potential %Expected upside potential %. Dalio RiskDalio Debt Cycle Score Debt/EquityDebt to Equity ratio.
009540
269,000.00 19,022.2B 5.52 1.28 1.55 59.3% 9.2% 89 87 715,325.51 +124.4% 83 0.17
439260
42,400.00 1,615.0B 5.37 1.35 3.17 29.5% 12.1% 89 83 99,468.38 +101.0% 97 0.00
005850
51,600.00 2,376.5B 6.23 0.88 3.41 12.0% 10.8% 87 67 130,774.35 +115.1% 90 0.14
004490
64,700.00 863.8B 6.06 0.51 3.55 6.1% 9.6% 84 67 178,824.21 +132.3% 87 0.18
007340
39,350.00 2,036.8B 5.25 0.85 4.74 11.0% 7.3% 83 73 97,719.70 +111.2% 66 0.94
005810
34,950.00 475.5B 4.57 0.39 4.59 7.0% 11.8% 82 48 75,597.67 +83.7% 80 0.08
009900
9,740.00 511.1B 5.74 0.60 4.09 7.3% 8.8% 82 66 26,257.82 +127.2% 72 0.54
064960
25,650.00 611.3B 7.38 0.59 3.11 8.7% 13.6% 82 51 59,411.58 +98.7% 93 0.00
071970
41,800.00 1,417.9B 7.28 2.72 5.28 53.1% 12.1% 82 80 76,307.89 +61.9% 89 0.01
100840
28,800.00 542.6B 4.94 1.35 2.99 27.6% 13.6% 82 58 56,186.95 +71.3% 99 0.01
002240
16,260.00 438.8B 9.03 0.23 2.69 1.0% 10.1% 82 36 36,547.56 +89.8% 77 0.11
036530
45,000.00 670.3B 6.74 0.47 1.16 15.4% 12.1% 82 71 124,879.33 +133.1% 88 0.07
017800
70,500.00 2,545.4B 6.93 2.35 5.19 10.1% 9.4% 79 59 126,562.16 +59.6% 65 1.01
075580
8,410.00 478.1B 7.46 1.95 6.01 13.5% 9.7% 78 62 15,200.53 +60.6% 64 1.04
064350
99,800.00 10,892.4B 13.49 3.20 7.44 71.9% 11.0% 75 77 138,735.63 +29.3% 87 0.05
000157
303,000.00 4,122.3B 11.21 1.58 4.36 10.3% 5.4% 72 62 602,050.48 +74.0% 41 4.14
000155
358,000.00 4,870.6B 13.24 1.87 4.68 10.3% 5.7% 70 61 645,979.41 +60.3% 41 4.14
042660
63,900.00 19,576.2B 9.44 2.60 11.50 10.5% 8.2% 68 48 76,535.43 +14.2% 65 0.82
047050
57,100.00 9,732.4B 11.75 1.39 8.10 7.2% 7.4% 66 35 64,875.17 +9.8% 61 1.14
006260
230,000.00 6,289.9B 14.70 1.19 8.76 6.8% 5.2% 65 66 388,295.13 +49.6% 45 2.52
018880
3,990.00 4,094.7B — 1.00 6.47 4.2% 7.8% 64 50 5,749.22 +28.2% 49 0.92
003570
29,400.00 732.6B 14.90 0.79 8.57 5.8% 12.1% 64 41 40,499.82 +27.2% 88 0.00
082740
37,100.00 3,095.1B 19.95 4.76 17.39 25.8% 11.0% 62 65 32,726.26 -8.8% 84 0.08
077970
18,520.00 743.4B 11.01 1.94 11.08 9.8% 9.4% 61 41 20,809.70 +8.3% 59 0.90
195870
49,000.00 833.0B 15.55 1.44 6.88 8.2% 10.0% 61 34 52,116.66 +4.6% 77 0.42
112610
54,600.00 2,272.1B 100.00 1.77 12.84 12.3% 9.7% 60 60 71,077.23 +19.3% 53 0.96
079900
35,000.00 508.5B 14.51 3.12 10.98 9.7% 13.1% 59 38 29,806.08 -10.7% 86 0.18
011930
16,230.00 33.0B — 0.15 12.80 0.7% 4.4% 53 45 28,969.72 +40.0% 31 1.01
006405
228,500.00 17,652.6B 100.00 0.73 11.96 -2.4% 7.2% 51 30 257,975.80 +7.6% 42 0.51
103590
64,800.00 3,089.5B 21.97 4.72 14.46 23.9% 10.8% 49 46 39,560.44 -29.2% 88 0.22
062040
187,100.00 5,721.9B 31.74 8.63 23.49 28.9% 11.1% 46 46 81,071.35 -42.5% 100 0.00
042700
207,000.00 19,634.6B 88.43 26.29 64.13 26.6% 10.1% 41 36 51,750.00 -56.2% 99 0.00
000150
1.1M 14,339.5B 38.99 5.49 8.76 10.3% 7.2% 40 47 660,547.40 -26.9% 41 4.14
006345
8,890.00 697.1B 55.16 4.76 29.12 7.2% 11.2% 36 25 3,046.78 -49.3% 80 0.50
034020
66,000.00 42,182.8B 100.00 5.17 33.72 4.5% 9.1% 35 24 18,638.05 -51.7% 49 0.91
020150
58,400.00 3,058.1B — 1.78 112.15 -4.1% 10.2% 34 18 39,115.92 -16.8% 57 0.20
006340
10,800.00 846.9B 67.01 5.78 35.19 7.2% 11.3% 33 23 3,257.23 -52.4% 82 0.50
000500
253,000.00 7,533.7B 100.00 14.21 63.04 6.2% 10.4% 30 18 63,250.00 -56.2% 66 1.21
001440
23,700.00 4,403.7B — 2.34 183.02 5.5% 9.3% 26 30 12,561.51 -30.1% 43 0.63

The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.